150 related articles for article (PubMed ID: 21225621)
21. [Antiangiogenic drugs enhance the ability of invasion and metastasis of breast cancer cells under serum starvation and hypoxia].
Wei L; Cuicui Z; Jing W; Kai L
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):244-50. PubMed ID: 26462887
[TBL] [Abstract][Full Text] [Related]
22. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
[TBL] [Abstract][Full Text] [Related]
24. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
25. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
[TBL] [Abstract][Full Text] [Related]
26. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.
Itasaka S; Komaki R; Herbst RS; Shibuya K; Shintani T; Hunter NR; Onn A; Bucana CD; Milas L; Ang KK; O'Reilly MS
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):870-8. PubMed ID: 17293237
[TBL] [Abstract][Full Text] [Related]
27. Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin.
Grossman R; Tyler B; Hwang L; Zadnik P; Lal B; Javaherian K; Brem H
J Neurosurg; 2011 Dec; 115(6):1139-46. PubMed ID: 21923243
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin Fc domain fusion to apolipoprotein(a) kringle V significantly prolongs plasma half-life without affecting its anti-angiogenic activity.
Yu HK; Lee HJ; Ahn JH; Lim IH; Moon JH; Yoon Y; Yi LS; Kim SJ; Kim JS
Protein Eng Des Sel; 2013 Jun; 26(6):425-32. PubMed ID: 23571426
[TBL] [Abstract][Full Text] [Related]
29. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis].
Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926
[TBL] [Abstract][Full Text] [Related]
30. Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor.
Li J; Ji J; Holmes LM; Burgin KE; Barton LB; Yu X; Wagner TE; Wei Y
Cancer Gene Ther; 2004 May; 11(5):363-70. PubMed ID: 15044960
[TBL] [Abstract][Full Text] [Related]
31. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
Li Y; Li L; Li Z; Sheng J; Zhang X; Feng D; Zhang X; Yin F; Wang A; Wang F
Biochim Biophys Acta; 2016 Oct; 1860(10):2137-47. PubMed ID: 27233450
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer.
Teoh D; Secord AA
Int J Gynecol Cancer; 2012 Mar; 22(3):348-59. PubMed ID: 22266932
[TBL] [Abstract][Full Text] [Related]
33. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells.
Dkhissi F; Lu H; Soria C; Opolon P; Griscelli F; Liu H; Khattar P; Mishal Z; Perricaudet M; Li H
Hum Gene Ther; 2003 Jul; 14(10):997-1008. PubMed ID: 12869217
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
[TBL] [Abstract][Full Text] [Related]
35. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.
Tatar O; Shinoda K; Kaiserling E; Claes C; Eckardt C; Eckert T; Pertile G; Boeyden V; Scharioth GB; Yoeruek E; Szurman P; Bartz-Schmidt KU; ; Grisanti S
Br J Ophthalmol; 2009 Feb; 93(2):159-65. PubMed ID: 18838410
[TBL] [Abstract][Full Text] [Related]
36. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
[TBL] [Abstract][Full Text] [Related]
37. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma.
Bertolini F; Fusetti L; Mancuso P; Gobbi A; Corsini C; Ferrucci PF; Martinelli G; Pruneri G
Blood; 2000 Jul; 96(1):282-7. PubMed ID: 10891463
[TBL] [Abstract][Full Text] [Related]
38. A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model.
Suzaki Y; Hamada K; Sho M; Ito T; Miyamoto K; Akashi S; Kashizuka H; Ikeda N; Nakajima Y; Iwase M; Homma I; Kobzik L; Kimura H
J Allergy Clin Immunol; 2005 Dec; 116(6):1220-7. PubMed ID: 16337449
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
40. [Inhibition of malignant ascites with endostatin adenoviral vector].
Wu Y; Zhao M; Yang L; Liu J; Wei YQ; Zhao X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):316-9. PubMed ID: 15181823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
